Atara Biotherapeutics, Inc.
ATRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,303 | $2,387 | $38,010 | -$12,693 |
| Dep. & Amort. | $36 | $236 | $1,795 | $1,100 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,801 | $4,209 | $5,846 |
| Change in WC | -$7,877 | -$12,771 | -$82,113 | -$22,405 |
| Other Non-Cash | $2,357 | $29 | $9,961 | $3,681 |
| Operating Cash Flow | -$9,787 | -$7,318 | -$28,138 | -$24,471 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $349 | $0 | -$90 |
| Net Acquisitions | $44 | $0 | $0 | $0 |
| Inv. Purchases | -$2,466 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $1 | $0 | $17,199 | $3,466 |
| Other Inv. Act. | $0 | -$5,419 | $0 | $0 |
| Investing Cash Flow | -$2,421 | -$5,070 | $17,199 | $3,376 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$250 | -$235 |
| Stock Issued | $1,035 | $0 | $0 | -$210 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $12 | $15,304 | $0 | $117 |
| Financing Cash Flow | $1,047 | $15,304 | -$250 | -$328 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,161 | $2,916 | -$11,189 | -$21,423 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,903 | $13,987 | $25,176 | $46,599 |
| End Cash | $5,742 | $16,903 | $13,987 | $25,176 |
| Free Cash Flow | -$9,787 | -$7,318 | -$28,138 | -$24,561 |